Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethinylestradiol/Gestodene Patch Ovulation Inhibition Study
NCT00873483Phase 2Completed
- Sponsor
- Bayer
- Start
- Apr 2009
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ethinyl estradiol + gestodene in contraception, sponsored by Bayer. Started Apr 2009; status: completed.
02
Drugs
ethinyl estradiol + gestodene
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00873483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00873483.